Economy

Economy
Economy

Why is the Lighter crypto price rising as the broader market falls?

Lighter’s token LIT has continued to climb even as wider crypto markets show weakness. The token is currently trading around $1.59, up 4% in the past 24 hours, and has outperformed many major assets during the same period. Over the past month, LIT has gained nearly 48.8%, showing a sustained upward trend rather than a

Read More
Economy

Nvidia stock is back in the red today: what’s hurting the AI darling?

Nvidia (NVDA) stock reversed early gains and traded lower on Tuesday, despite Apple confirming that some of its artificial intelligence services will run on Nvidia hardware as part of the iPhone maker’s broader AI strategy. Shares of Nvidia fell 1.3% to $206.13 in early trading. The decline came as broader markets weakened following a sharp

Read More
Economy

Micron stock falls on Tuesday: Why analysts still see gains ahead

Micron MU shares fell 1.7% on Tuesday, reversing a small portion of its 10% gains on Monday. The decline came after a volatile period for semiconductor stocks, with Micron shares having fallen about 20% over two trading days last week, including a 13% plunge on Friday. Despite the recent pullback, Wall Street analysts remain overwhelmingly

Read More
Economy

Citi trims 3-month gold target to $4,000 on softer demand

Citigroup has lowered its near-term outlook for gold to $4,000. The bank cited improving macroeconomic conditions, moderating investor demand, and easing geopolitical tensions as factors that could limit further gains in the precious metal over the coming months. In a research note published Monday, Citi’s commodities research team reduced its three-month gold price target to

Read More
Economy

Jensen Huang strikes again, recommends buying Qualcomm stock

Nvidia chief executive Jensen Huang brought Qualcomm (QCOM) in focus late Monday, issuing an explicit public endorsement of the rival chipmaker. Speaking to tech executives and reporters during his highly anticipated press tour in Seoul, Huang praised QCOM’s dominance in mobile hardware before playfully instructing the audience to “buy their stock” The unscripted remarks caught

Read More
Economy

Why Tesla stock is crashing around 5% today

Tesla stock (TSLA) plunged around 5% on Tuesday, giving back much of the previous session’s gains as a broader selloff in technology and semiconductor stocks weighed heavily on investor sentiment. The electric-vehicle maker’s stock had surged roughly 4.5% on Monday but reversed sharply as risk appetite faded across the market. US equities broadly declined on

Read More
Economy

Apple stock falls 4% after AI reveal despite analyst optimism on Siri

Apple AAPL shares fell 4.4% on Tuesday, a day after the company unveiled a series of artificial intelligence initiatives at its annual Worldwide Developers Conference (WWDC). The decline put the stock on track for its worst daily performance since February. The move came despite largely positive reactions from analysts to Apple’s latest AI announcements, including

Read More
Economy

Veeco stock soars on NSA500 order as chip demand gains momentum

Shares of Veeco Instruments VECO moved sharply higher on Tuesday after the semiconductor equipment maker announced a follow-on order for its Nanosecond Annealing System (NSA500). The move signals growing customer confidence in the company’s technology for advanced chip manufacturing. The stock gained as much as 19% during the session, extending its recent rally. At the

Read More
Economy

Monero (XMR) price forecast: Can the Cake Wallet integration spur a rebound?

Monero (XMR) price is down 21.5% over the past 30 days and sits nearly 60% below its all-time high of $797.73, which it reached on January 14, 2026. In the past 24 hours, the coin has pushed back up to around $326, gaining more than 2% on the day. The question now is whether this

Read More
Economy

AstraZeneca’s obesity drug shows promise as analysts see upside beyond consensus

AstraZeneca is emerging as a potential new contender in the booming obesity treatment market after its experimental weight-loss pill delivered encouraging mid-stage trial results, prompting investors and analysts to reassess whether the British drugmaker can challenge the dominance of Novo Nordisk and Eli Lilly. The company said on Monday that patients receiving the highest dose

Read More